TickerFacts.

A business in context

AXSM research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-03 · 0001193125-26-382277

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-342360

  3. 8-K · Current report

    Report date 2026-08-10 · 0001193125-26-341206 · Items 2.02,8.01,9.01

  4. 4 · Ownership change

    Report date 2026-08-05 · 0001193125-26-340688

  5. 8-K · Current report

    Report date 2026-07-15 · 0001193125-26-304039 · Items 8.01,9.01

  6. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-292985

  7. 4 · Ownership change

    Report date 2026-06-10 · 0001193125-26-268202

  8. 4 · Ownership change

    Report date 2026-06-08 · 0001193125-26-266437

  9. 4 · Ownership change

    Report date 2026-06-08 · 0001193125-26-266436

  10. 4 · Ownership change

    Report date 2026-06-08 · 0001193125-26-266435

  11. 4 · Ownership change

    Report date 2026-06-08 · 0001193125-26-266433

  12. 8-K · Current report

    Report date 2026-06-05 · 0001193125-26-264047 · Items 5.02,9.01

  13. 8-K · Current report

    Report date 2026-06-05 · 0001193125-26-264043 · Items 5.07,9.01

  14. 8-K · Current report

    Report date 2026-06-03 · 0001193125-26-254708 · Items 8.01,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-204274

  16. 8-K · Current report

    Report date 2026-05-04 · 0001193125-26-202506 · Items 2.02,8.01,9.01

  17. 8-K · Current report

    Report date 2026-04-30 · 0001193125-26-197857 · Items 8.01,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-04-24 · 0001193125-26-177610

  19. 8-K · Current report

    Report date 2026-04-01 · 0001193125-26-135669 · Items 8.01,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-064267

  21. 8-K · Current report

    Report date 2026-02-23 · 0001193125-26-062421 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2026-02-17 · 0001193125-26-053009 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2026-01-12 · 0001193125-26-009744 · Items 2.02,8.01,9.01

  24. 8-K · Current report

    Report date 2025-12-31 · 0001193125-25-337644 · Items 8.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-262664

  26. 8-K · Current report

    Report date 2025-11-03 · 0001193125-25-261651 · Items 2.02,8.01,9.01

  27. 8-K · Current report

    Report date 2025-08-19 · 0001579428-25-000007 · Items 8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-102148

  29. 8-K · Current report

    Report date 2025-08-04 · 0000950170-25-101624 · Items 2.02,8.01,9.01

  30. 8-K · Current report

    Report date 2025-06-10 · 0000950170-25-084098 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2025-06-06 · 0000950170-25-083793 · Items 5.07,9.01

  32. 8-K · Current report

    Report date 2025-06-09 · 0000950170-25-083441 · Items 8.01,9.01

  33. 8-K · Current report

    Report date 2025-05-27 · 0000950170-25-077374 · Items 8.01,9.01

  34. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-069785 · Items 1.01,1.02,2.03,3.02,8.01,9.01

  35. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-063634

  36. 8-K · Current report

    Report date 2025-05-05 · 0000950170-25-063158 · Items 2.02,8.01,9.01

  37. DEF 14A · Proxy statement

    Report date 2025-04-25 · 0000950170-25-058781

  38. 8-K · Current report

    Report date 2025-04-01 · 0000950170-25-048036 · Items 8.01,9.01

  39. 8-K · Current report

    Report date 2025-03-25 · 0000950170-25-044096 · Items 8.01,9.01

  40. 8-K · Current report

    Report date 2025-03-05 · 0000950170-25-033064 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 4 transaction rows4SGrant / award: 0 transaction rows0AExercise / conversion: 8 transaction rows8MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

12 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-03
2026-09-03
Jacobson Mark L.S · Sale
Disposed
Common Stock10000.0208.65
2026-09-03
2026-09-03
Jacobson Mark L.M · Exercise / conversion
Acquired
Common Stock10000.012.95
2026-09-03
2026-09-03
Jacobson Mark L.M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
10000.00.0
2026-08-06
2026-08-07
TABUTEAU HERRIOTS · Sale
Disposed
Common Stock4660.0213.95
2026-08-06
2026-08-07
TABUTEAU HERRIOTM · Exercise / conversion
Acquired
Common Stock4660.04.95
2026-08-06
2026-08-07
TABUTEAU HERRIOTM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
4660.00.0
2026-08-05
2026-08-07
TABUTEAU HERRIOTS · Sale
Disposed
Common Stock45004.0212.01
2026-08-05
2026-08-07
TABUTEAU HERRIOTM · Exercise / conversion
Acquired
Common Stock45004.04.95
2026-08-05
2026-08-07
TABUTEAU HERRIOTM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
45004.00.0
2026-07-01
2026-07-01
TABUTEAU HERRIOTM · Exercise / conversion
Acquired
Common Stock49666.04.95
2026-07-01
2026-07-01
TABUTEAU HERRIOTS · Sale
Disposed
Common Stock49666.0240.25
2026-07-01
2026-07-01
TABUTEAU HERRIOTM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
49666.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001579428Axsome Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$385.69M$414.27M
    2023-12-31$270.60M$299.21M
    2022-12-31$50.04M$57.60M

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗